The agreement was signed on Wednesday between the Institute Pasteur of Iran (PII) and India’s Bharat Biotech Vaccine Manufacturing Company during a webinar held in the presence of presidents of Pasteur Institute of Iran and India’s Bharat Biotech Vaccine Manufacturing Company, Mehr News Agency reported.
Rotavirus is the most common cause of severe diarrhea in children, and almost every child becomes infected at least once before the age of five.
It is estimated that more than 500,000 children under the age of 5 die each year by Rotavirus.
Based on the agreement, a contract was inked between the two sides in order to supply ‘Rotavirus’ vaccine for being used in domestic vaccination system and also transfer of technology for domestic production of the vaccine in Iran.
The ambassadors of both countries, as well as officials from the ministries of health and foreign affairs of Iran and India, were also present at the virtual meeting.